Gene Query: HMGCS2

Dataset Description Geneva Score
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 260.86
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 145.44
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 121.39
Identifying the molecular mode of action of itraconazole in colorectal cancer 112.39
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 76.55
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 72.31
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 69.15
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 65.03
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 63.95
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 63.95
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 62.04
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 62.03
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 53.66
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 53.66
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 53.41
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 53.31
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 52.06
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 51.98
Single-nucleotide-resolution mapping of HBV promoters using CAGE 50.76
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 50.56
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 48.9
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 48.9
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 46.55
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 46.55
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 44.53
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 44.53
RNA seq analysis of human Fetal and adult derived Enterospheres 40.49
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 39.59
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 37.04
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 34.07
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 33.49
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 31.7
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 31.59
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 31.58
Identification of HOXB13 target genes responsive to BET inhibitors 31.47
The expression profiles of GBC liver metastasis 31.11
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 30.28
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 30.28
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 28.35
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 27.46
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 27.46
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 27.29
mRNA-Seq profiling of human developing kidney 26.72
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 26.29
Androgen Receptor-regulated genes in prostate cancer cells 26.29
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 26.11
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 26.1
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 26.1
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 26.09
Epigenomic landscape during organ formation in human early embryos 25.75
Role for citron kinase in prostate cancer growth 25.71
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 24.75
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 24.12
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 24.07
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 23.92
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 23.92
Transcriptome analysis of H9 hESC derived cerebral organoids 23.21
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 22.32
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 22.13
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 22.02
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 22.01
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 22.0
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 21.75
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 21.53
Gene expression analysis of human liver progenitor-like cells in culture 21.44
High-Throughput Kinetic Analysis of Fractional Killing 21.41
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 21.31
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 20.24
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 20.22
Total RNA sequencing of WT intestinal orgaonids. 19.81
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 19.64
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 19.19
Differentially expressed genes post knock down of lincDUSP26 19.0
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 18.72
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 18.6
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 18.6
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 18.38
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 18.24
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 18.19
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 18.05
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 18.02
Transcriptome profiling of Normal and Cancerous Prostate Cells 17.78
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 17.12
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 17.06
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 16.82
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 16.74
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 16.74
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 16.61
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 16.43
Gene expression analysis of immortalized human liver progenitor-like cells in culture 16.03
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 15.9
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 15.77
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 15.55
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 15.55
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 15.51
RNA sequencing of matched nephrectomy samples [RNA-seq] 15.22
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 15.22
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 14.89
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 14.87
Paxillin regulates genomic networks in prostate cancer [LNCaP] 14.67
Total RNA sequencing of APC mutant and wt colonic organoids 14.43
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 14.04
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 14.04
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 14.0
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 13.83
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 13.79
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 13.18
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 13.16
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 12.82
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 12.69
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 12.57
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 12.41
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 12.29
Postnatal lipids drive hepatocyte maturation 12.21
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 12.13
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 12.13
Identification of a LIF-responsive replication-competent human β cell 11.89
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 11.74
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 11.51
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 11.49
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 11.24
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 11.24
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 11.23
Dtx3L and Androgen Signaling in Prostate Cancer 11.03
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 10.82
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 10.82
RNA-seq analysis of the human fetal kidney. 10.73
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 10.62
Genome-wide functional assessment of enhancer activities in the human genome 10.34
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 10.31
RNA Sequencing of three pairs of gastric cancer 9.99
Transcriptome analysis of kidney organoids 9.96
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 9.88
Gene expression patterns define the hepatocyte-like cells derived by different strategies 9.88
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 9.78
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 9.69
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 9.32
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 9.17
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 8.85
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 8.59
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 8.59
Effect of PBK knockdown on C4-2 cell transcriptome 8.54
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 8.02
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 8.0
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 7.89
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 7.86
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 7.85
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 7.78
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 7.63
RNA-sequencing 7.59
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 7.54
The gene expression profiles of gallbladder cancer 7.19
Paxillin regulates genomic networks in prostate cancer [C4-2] 7.19
Repurposing of promoters and enhancers during mammalian evolution 6.87
An optimization system for isolating and sequencing of single human colon cancer cells 6.83
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 6.59
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 6.54
RNAseq analysis of ESRP regulated splicing events in prostate cancer 6.47
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 6.33
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 6.23
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 6.22
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 6.13
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 6.12
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 6.1
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 5.97
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 5.77
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 5.71
HNRNPM-regulated splicing dependencies in prostate cancer 5.71
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 5.66
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 5.55
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 5.37
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 5.36
HNRNPL and its RNA Targets in Prostate Cancer 5.35
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 5.35
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 5.32
T47D RNA-seq and ChrRNA-seq data 5.32
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 5.28
RNA-Seq analysis of human colorectal cancer with liver metastasis 5.26
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 5.19
A practical evaluation of alignment algorithms for RNA variant calling analysis 5.12
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 5.03
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 4.88
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 4.88
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 4.76
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 4.66
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 4.59
Genome-wide Analysis of Chromatin Interactions in Human Cells 4.55
Single-cell analysis of adult human ovary using 10X genomics 4.51
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 4.49
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 4.46
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 4.39
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 4.35
RNA-seq analysis and shRNA screen of breast cancer 4.27
RNA-seq analysis of breast cancer 4.27
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 4.24
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 4.08
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 4.07
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 4.06
Derivation and differentiation of haploid human embryonic stem cells 3.99
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 3.89
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 3.89
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 3.82
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 3.81
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 3.81
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 3.79
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 3.79
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 3.68
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 3.68
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 3.63
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 3.59
RNA-seq differential expression studies: more sequence, or more replication? 3.52
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 3.51
Gene expression profile difference among renal location in a stone former 3.48
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 3.46
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 3.41
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 3.41
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 3.23
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 3.15
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 3.03
Transcriptional profiling of LS1034 cells treated with tepoxalin 3.01
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 3.0
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 3.0
CDK4/6 inhibitor resistance in prostate cancer 2.94
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 2.92
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.88
Transcriptome of human white and brown adipose tissue biopsies 2.78
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 2.75
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 2.73
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 2.73
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 2.71
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 2.7
Comparing gene expression in iPSC derived RPE from control and AMD donors 2.64
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.59
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 2.58
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 2.56
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 2.53
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 2.43
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 2.38
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 2.37
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 2.35
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.34
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 2.34
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 2.32
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 2.25
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 2.2
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 2.18
RNAseq analysis of ruxolitinib treated breast cancers 2.14
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 2.1
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 2.1
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 2.08
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 2.07
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 2.04
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 1.99
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.99
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 1.97
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 1.92
Hepatocyte maturation 1.92
mRNA-sequencing of breast cancer subtypes and normal tissue 1.9
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 1.9
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 1.87
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 1.84
RNA-Seq with and without RNase treatment in PCa cell lines 1.73
Universal alternative splicing of noncoding exons 1.72
RNAseq of Breast cancer PDX samples 1.71
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 1.7
ML29755 RNA-seq data 1.7
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 1.68
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 1.66
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 1.64
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 1.63
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 1.62
The role of the Calcium-Sensing receptor in colorectal cancer 1.58
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 1.56
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 1.56
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 1.55
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.53
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 1.52
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 1.51
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 1.5
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 1.5
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 1.5
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 1.5
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 1.46
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 1.44
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 1.43
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 1.43
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 1.41
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 1.39
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 1.39
RNA-seq analyses of human prostate cancer cells 1.39
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 1.38
Transcriptomic profile of human embryonic renal corpuscles 1.36
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 1.35
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 1.35
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 1.34
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 1.34
Gene expression alterations of pancreatic intraepithlial neoplasia 1.32
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 1.3
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 1.3
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 1.25
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 1.25
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 1.25
Global expression profiles in cardiac progenitor cells generated by ISX-9 1.25
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 1.24
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 1.24
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 1.2
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 1.18
Gene expression of collecting duct carcinoma of the kidney 1.18
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 1.15
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 1.14
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 1.11
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 1.09
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 1.09
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 1.09
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 1.08
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 1.08
Genome-wide identification of cancer-specific alternative splicing in circRNA 1.08
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 1.07
The conserved transcriptional landscapes in human spermatogenesis 1.06
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 1.06
Global analyses of the effect of different cellular contexts on microRNA targeting 1.05
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 1.05
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 1.05
Cerebellar differentiation in Ataxia-Telangiectasia 1.03
Preclinical model of obesity and ER-positive breast cancer 0.95
Lipid degradation promotes prostate cancer cell survival 0.93
Transcriptomic analysis of frontal fibrosing alopecia 0.92
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 0.92
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.9
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.86
Gene expression analysis of breast cancer cell-lines 0.86
Common inflammatory pathways between NEC and Crohn's disease 0.83
Gene expression analysis of human adenomas. 0.82
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 0.82
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 0.82
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.81
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.81
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 0.78
Transcriptome analysis of human lung epithelial cells 0.78
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 0.77
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 0.76
Measure transcript integrity using RNA-seq data 0.75
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 0.74
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.73
Transcriptional landscape changes during human embryonic stem cell derivation 0.72
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.71
Dilated cardiomyopathy vs Myocarditis 0.7
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 0.69
The Human Testis Cell Atlas via Single-cell RNA-seq 0.67
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 0.67
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 0.66
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 0.65
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 0.65
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 0.65
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.64
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.63
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.63
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 0.62
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 0.61
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.6
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 0.6
Effect of CHKA knockdown on C4-2 cell transcriptome 0.59
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.58
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 0.57
RNA-seq analysis to identify the genes regulated by p53-SET interplay 0.54
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 0.52
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 0.51
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 0.5
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.49
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.49
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 0.49
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 0.48
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.47
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 0.45
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 0.45
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 0.44
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 0.44
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.44
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.44
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 0.43
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 0.42
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.41
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.41
Fusion discovery in breast cancer cell line 0.41
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 0.41
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 0.41
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 0.41
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 0.4
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 0.4
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 0.4
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 0.4
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 0.4
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 0.39
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 0.39
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.39
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 0.39
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 0.39
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 0.38
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.38
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 0.37
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.36
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 0.36
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.36
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.35
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.34
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.34
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 0.34
Gene profiling of human adult and pediatric liver cancer cells 0.34
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 0.33
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 0.33
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 0.32
Engineering Patient-Specific Tissue Implants 0.32
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 0.31
Patient-derived luminal breast cancer xenografts with progestins 0.31
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.31
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 0.31
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 0.3
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 0.3
RNA-seq of SCLC PDX models treated with EP 0.3
Deep RNA sequencing of the human placental transcriptome 0.29
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 0.29
Reprogrammed myeloid cell transcriptomes in NSCLC 0.28
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.28
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.28
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.27
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 0.27
Identification of expressed and conserved human non-coding RNAs 0.27
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 0.26
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 0.26
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 0.26
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 0.25
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.25
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.25
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 0.25
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 0.24
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 0.24
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.23
RNA-seq in HepG2 and IMR90 cells 0.23
Evolution of a transcriptional regulator from a transmembrane nucleoporin 0.23
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.22
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 0.22
Identification of global XBP1s target gene expression in human prostate cancer cells 0.22
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.22
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.21
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 0.21
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.2
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.2
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 0.2
Neonatal and adult human testis defined at the single-cell level 0.2
Alagille_Nodder 0.19
RNA Seq of Alagille liver biopsies 0.19
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.19
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 0.19
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.18
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.18
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 0.17
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.17
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 0.17
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 0.16
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.16
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.16
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 0.16
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.15
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.15
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 0.14
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.14
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.14
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 0.14
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 0.14
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 0.13
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 0.12
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 0.12
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 0.12
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 0.11
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 0.11
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.1
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 0.1
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.1
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.08
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.08
Hepatic transcriptome of pediatric hepatoblastoma. 0.08
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 0.07
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 0.07
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 0.07
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.07
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 0.06
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.05
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.04
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 0.04
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.03
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 0.03
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.03
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 0.03
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 0.03
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.03
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.03
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.02
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.02
Persistence of stem cell metabolism in cancers as a failure of differentiation 0.0
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation